{
    "sourceOrganization": [
        {
            "@type": "ResearchProject",
            "name": "NIAID GHAVE",
            "abstract": "The Global HIV Vaccine Enterprise (GHAVE) is an international alliance of public and private partners collaborating to accelerate HIV vaccine development. While maintaining independent decision-making, member organizations coordinate efforts to advance research and clinical trials.",
            "description": "An effective and widely available vaccine will be central to any global strategy to slow and end the HIV pandemic. Recognizing the need for increased cooperation, 30+ international organizations joined forces, forming the Global HIV Vaccine Enterprise (GHAVE), a voluntary alliance of public and private partners committed to working together, while maintaining independent decision-making authority. For more information, visit the NIAID program page: https://www.niaid.nih.gov/research/global-hiv-vaccine-enterprise",
            "alternateName": [
                "GHAVE",
                "Global HIV Vaccine Enterprise"
            ],
            "url": "https://www.iasociety.org/ias-programme/global-hiv-vaccine-enterprise",
            "parentOrganization": [
                "NIAID",
                "Bill and Melinda Gates Foundation"
            ]
        }
    ]
}